Abivax
ABVX
48 hedge funds and large institutions have $219M invested in Abivax in 2024 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 14 increasing their positions, 9 reducing their positions, and 6 closing their positions.
133% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 6
56% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 9
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
20% more funds holding
Funds holding: 40 → 48 (+8)
3.88% more ownership
Funds ownership: 43.26% → 47.14% (+3.9%)
30% less capital invested
Capital invested by funds: $313M → $219M (-$94.3M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
+$9.13M |
| 2 |
CP
Caligan Partners
New York
|
+$6.92M |
| 3 |
JP Morgan Chase
New York
|
+$6.71M |
| 4 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$4.15M |
| 5 |
BFM
Boothbay Fund Management
New York
|
+$3.75M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
-$6.12M |
| 2 |
Blackstone Inc
New York
|
-$5.39M |
| 3 |
Janus Henderson Group
London,
United Kingdom
|
-$4.74M |
| 4 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$4.42M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$4.16M |
ABVX Hedge Fund Activity: Q4 2024 in Review
48 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Abivax (ABVX) for Q4 2024, worth a combined $219M — down 30% from $313M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new ABVX positions and 6 closed out — a net gain of 8 holders — while 14 added to existing stakes and 9 trimmed.
The largest buyer was ADAR1 Capital Management, adding an estimated $9.13M. The largest seller was Adage Capital Partners, exiting entirely with an estimated $6.12M sold.
- 48 institutional investors held Abivax (ABVX) as of Q4 2024, up from 40 in Q3 2024.
- Funds reported $219M of Abivax stock for Q4 2024, down 30% quarter-over-quarter.
- 14 funds opened new Abivax positions in Q4 2024 and 6 closed out, a net change of +8 holders.
- The largest Abivax buyer in Q4 2024 was ADAR1 Capital Management, an estimated $9.13M added.
- The largest Abivax seller in Q4 2024 was Adage Capital Partners, an estimated $6.12M sold.
Based on aggregated 13F filings for Q4 2024.